9:22 AM
Leo Group India
| ||
| Valeant Pharmaceuticals International's shares shoot higher on Medicis ... Economic Times Valeant Pharmaceuticals International Inc's stock jumped 15 per cent on Tuesday morning on news of the Canadian drugmaker's $2.6 billion deal to take over US dermatology competitor Medicis Pharmaceutical Corp. Medicis stock rose 38.0 per cent to ... See all stories on this topic » | ||
| Pharmaceutical companies told to submit safety reports on new drugs every 6 ... Economic Times NEW DELHI: In an effort to plug some worrying gaps, the country's drug regulator has asked pharma companies to submit the mandatory safety details of their new drugs for every six months for the first two years from their launch, failing which, it ... See all stories on this topic » | ||
| US Movers: Campbell Soup, Heckmann, Quanex, Valeant Pharmaceuticals 123Jump.com 10:10 AM New York – Campbell Soup net jumped 27% and issued fiscal guidance. Heckmann to buy Power Fuels total valued approx $370 million. Smithfield Foods net declined 25%. Valeant Pharmaceuticals to acquire Medicis Pharmaceutical for $2.6 ... See all stories on this topic » | ||
| REXAHN PHARMACEUTICALS, INC. : Rexahn Pharmaceuticals Provides ... 4-traders Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today provided an update on its strategic business goals for 2012. "I am pleased to ... See all stories on this topic » | ||
| Valeant Pharmaceuticals - Acquisition Spree Continues After $2.4 Billion ... Seeking Alpha Valeant Pharmaceuticals (VRX) announced on Labor day that it will acquire Medicis Pharmaceutical (MRX), in a deal valuing the firm at $2.6 billion. The Deal. Valeant Pharmaceuticals announced that it will acquire Medicis Pharmaceuticals, in an attempt ... See all stories on this topic » | ||
| Canada's Valeant Pharmaceuticals agrees to buy rival Medicis for about $2.6B Washington Post TORONTO — Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin treatments and care. Montreal-based Valeant ... See all stories on this topic » | ||
| Valeant to Buy Medicis Pharmaceutical for $2.6 Billion Businessweek Valeant Pharmaceuticals International Inc. (VRX)'s $2.6 billion agreement to purchase Medicis Pharmaceutical Corp. recharges an acquisition strategy that had stumbled with last year's failed bid for Cephalon Inc. Valeant, Canada's largest publicly ... See all stories on this topic » | ||
| BioSante Pharmaceuticals Announces Positive LibiGel® Phase III Safety Data ... 4-traders BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that the independent Data Monitoring Committee (DMC) has completed the ninth unblinded review of the LibiGel Phase III cardiovascular events and breast cancer safety study. See all stories on this topic » | ||
| Government to ban over-the-counter sale of 92 antibiotics Economic Times The Centre said that based on pharmaceutical audit data from IMS Health's Multinational Integrated Data Analysis System (MIDAS), the size of the carbapenem retail market in India was $27.4 million (Rs 119.4 crore) in 2010. The drugs to come under H1 ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment